Logo image of ALLEX.PA

LEXIBOOK LINGUISTIC ELECTRON (ALLEX.PA) Stock Fundamental Analysis

EPA:ALLEX - Euronext Paris - Matif - FR0000033599 - Common Stock - Currency: EUR

5.36  -0.1 (-1.83%)

Fundamental Rating

6

ALLEX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 30 industry peers in the Household Durables industry. ALLEX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ALLEX is not valued too expensively and it also shows a decent growth rate. This makes ALLEX very considerable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

ALLEX had positive earnings in the past year.
ALLEX had a positive operating cash flow in the past year.
Of the past 5 years ALLEX 4 years were profitable.
ALLEX had a positive operating cash flow in 4 of the past 5 years.
ALLEX.PA Yearly Net Income VS EBIT VS OCF VS FCFALLEX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

1.2 Ratios

With an excellent Return On Assets value of 8.77%, ALLEX belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
ALLEX has a better Return On Equity (22.61%) than 90.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 14.66%, ALLEX belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
ALLEX had an Average Return On Invested Capital over the past 3 years of 25.24%. This is significantly above the industry average of 15.82%.
The last Return On Invested Capital (14.66%) for ALLEX is well below the 3 year average (25.24%), which needs to be investigated, but indicates that ALLEX had better years and this may not be a problem.
Industry RankSector Rank
ROA 8.77%
ROE 22.61%
ROIC 14.66%
ROA(3y)12.57%
ROA(5y)9.27%
ROE(3y)32.18%
ROE(5y)24.79%
ROIC(3y)25.24%
ROIC(5y)19.65%
ALLEX.PA Yearly ROA, ROE, ROICALLEX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

ALLEX has a Profit Margin of 7.12%. This is in the better half of the industry: ALLEX outperforms 80.00% of its industry peers.
ALLEX's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 7.99%, ALLEX is doing good in the industry, outperforming 73.33% of the companies in the same industry.
In the last couple of years the Operating Margin of ALLEX has grown nicely.
ALLEX's Gross Margin of 21.48% is on the low side compared to the rest of the industry. ALLEX is outperformed by 80.00% of its industry peers.
ALLEX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.99%
PM (TTM) 7.12%
GM 21.48%
OM growth 3Y7.5%
OM growth 5YN/A
PM growth 3Y13.95%
PM growth 5YN/A
GM growth 3Y0.74%
GM growth 5Y-0.05%
ALLEX.PA Yearly Profit, Operating, Gross MarginsALLEX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ALLEX is creating value.
The number of shares outstanding for ALLEX remains at a similar level compared to 1 year ago.
The number of shares outstanding for ALLEX has been increased compared to 5 years ago.
The debt/assets ratio for ALLEX has been reduced compared to a year ago.
ALLEX.PA Yearly Shares OutstandingALLEX.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ALLEX.PA Yearly Total Debt VS Total AssetsALLEX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

ALLEX has an Altman-Z score of 3.20. This indicates that ALLEX is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.20, ALLEX is doing good in the industry, outperforming 73.33% of the companies in the same industry.
ALLEX has a debt to FCF ratio of 1.18. This is a very positive value and a sign of high solvency as it would only need 1.18 years to pay back of all of its debts.
ALLEX's Debt to FCF ratio of 1.18 is amongst the best of the industry. ALLEX outperforms 90.00% of its industry peers.
ALLEX has a Debt/Equity ratio of 0.52. This is a neutral value indicating ALLEX is somewhat dependend on debt financing.
The Debt to Equity ratio of ALLEX (0.52) is comparable to the rest of the industry.
Although ALLEX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 1.18
Altman-Z 3.2
ROIC/WACC1.97
WACC7.45%
ALLEX.PA Yearly LT Debt VS Equity VS FCFALLEX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

ALLEX has a Current Ratio of 2.02. This indicates that ALLEX is financially healthy and has no problem in meeting its short term obligations.
ALLEX's Current ratio of 2.02 is fine compared to the rest of the industry. ALLEX outperforms 70.00% of its industry peers.
ALLEX has a Quick Ratio of 2.02. This is a bad value and indicates that ALLEX is not financially healthy enough and could expect problems in meeting its short term obligations.
ALLEX has a Quick ratio (0.90) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 0.9
ALLEX.PA Yearly Current Assets VS Current LiabilitesALLEX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

5

3. Growth

3.1 Past

ALLEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.18%.
Measured over the past years, ALLEX shows a very strong growth in Earnings Per Share. The EPS has been growing by 46.92% on average per year.
Looking at the last year, ALLEX shows a quite strong growth in Revenue. The Revenue has grown by 15.06% in the last year.
The Revenue has been growing by 22.30% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-11.18%
EPS 3Y46.92%
EPS 5YN/A
EPS Q2Q%-21.08%
Revenue 1Y (TTM)15.06%
Revenue growth 3Y28.92%
Revenue growth 5Y22.3%
Sales Q2Q%10.89%

3.2 Future

ALLEX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.52% yearly.
Based on estimates for the next years, ALLEX will show a small growth in Revenue. The Revenue will grow by 5.04% on average per year.
EPS Next Y-10.94%
EPS Next 2Y-0.78%
EPS Next 3Y3.52%
EPS Next 5YN/A
Revenue Next Year5.13%
Revenue Next 2Y5%
Revenue Next 3Y5.04%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALLEX.PA Yearly Revenue VS EstimatesALLEX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ALLEX.PA Yearly EPS VS EstimatesALLEX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 9.57, which indicates a very decent valuation of ALLEX.
73.33% of the companies in the same industry are more expensive than ALLEX, based on the Price/Earnings ratio.
ALLEX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.98.
A Price/Forward Earnings ratio of 8.26 indicates a reasonable valuation of ALLEX.
ALLEX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ALLEX is cheaper than 66.67% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.49. ALLEX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.57
Fwd PE 8.26
ALLEX.PA Price Earnings VS Forward Price EarningsALLEX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

60.00% of the companies in the same industry are cheaper than ALLEX, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ALLEX is valued cheaply inside the industry as 93.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.19
EV/EBITDA 7.35
ALLEX.PA Per share dataALLEX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The excellent profitability rating of ALLEX may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.78%
EPS Next 3Y3.52%

0

5. Dividend

5.1 Amount

ALLEX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LEXIBOOK LINGUISTIC ELECTRON

EPA:ALLEX (6/27/2025, 7:00:00 PM)

5.36

-0.1 (-1.83%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)06-28 2025-06-28/amc
Earnings (Next)N/A N/A
Inst Owners15.06%
Inst Owner ChangeN/A
Ins Owners47.03%
Ins Owner ChangeN/A
Market Cap41.59M
Analysts86.67
Price Target6.12 (14.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.57
Fwd PE 8.26
P/S 0.68
P/FCF 4.19
P/OCF 3.82
P/B 2.16
P/tB 2.23
EV/EBITDA 7.35
EPS(TTM)0.56
EY10.45%
EPS(NY)0.65
Fwd EY12.11%
FCF(TTM)1.28
FCFY23.89%
OCF(TTM)1.4
OCFY26.21%
SpS7.87
BVpS2.48
TBVpS2.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.77%
ROE 22.61%
ROCE 18.57%
ROIC 14.66%
ROICexc 17.21%
ROICexgc 17.61%
OM 7.99%
PM (TTM) 7.12%
GM 21.48%
FCFM 16.28%
ROA(3y)12.57%
ROA(5y)9.27%
ROE(3y)32.18%
ROE(5y)24.79%
ROIC(3y)25.24%
ROIC(5y)19.65%
ROICexc(3y)34.45%
ROICexc(5y)27.67%
ROICexgc(3y)37.59%
ROICexgc(5y)30.99%
ROCE(3y)29.4%
ROCE(5y)22.75%
ROICexcg growth 3Y6.36%
ROICexcg growth 5YN/A
ROICexc growth 3Y8.61%
ROICexc growth 5YN/A
OM growth 3Y7.5%
OM growth 5YN/A
PM growth 3Y13.95%
PM growth 5YN/A
GM growth 3Y0.74%
GM growth 5Y-0.05%
F-Score6
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 1.18
Debt/EBITDA 1.61
Cap/Depr 73.54%
Cap/Sales 1.58%
Interest Coverage 13
Cash Conversion 176.21%
Profit Quality 228.57%
Current Ratio 2.02
Quick Ratio 0.9
Altman-Z 3.2
F-Score6
WACC7.45%
ROIC/WACC1.97
Cap/Depr(3y)97.17%
Cap/Depr(5y)61.96%
Cap/Sales(3y)2.12%
Cap/Sales(5y)1.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.18%
EPS 3Y46.92%
EPS 5YN/A
EPS Q2Q%-21.08%
EPS Next Y-10.94%
EPS Next 2Y-0.78%
EPS Next 3Y3.52%
EPS Next 5YN/A
Revenue 1Y (TTM)15.06%
Revenue growth 3Y28.92%
Revenue growth 5Y22.3%
Sales Q2Q%10.89%
Revenue Next Year5.13%
Revenue Next 2Y5%
Revenue Next 3Y5.04%
Revenue Next 5YN/A
EBIT growth 1Y-9.51%
EBIT growth 3Y38.59%
EBIT growth 5YN/A
EBIT Next Year11.86%
EBIT Next 3Y10.68%
EBIT Next 5YN/A
FCF growth 1Y273.41%
FCF growth 3Y59.8%
FCF growth 5YN/A
OCF growth 1Y295.69%
OCF growth 3Y65.21%
OCF growth 5YN/A